Interestingly, in two glioblastoma cell lines and a breast cancer cell line in which Akt was hyperactivated due to loss of PTEN, AMPK was rather resistant to activation and Thr172 phosphorylation induced by the activator A769662. This evidence concerns the gene PTEN and breast carcinoma.